A COMPARISON OF DRUG-BINDING SITES ON MAMMALIAN ALBUMINS

被引:38
|
作者
PANJEHSHAHIN, MR [1 ]
YATES, MS [1 ]
BOWMER, CJ [1 ]
机构
[1] UNIV LEEDS,DEPT PHARMACOL,WORSLEY MED & DENT BLDG,LEEDS LS2 9JT,W YORKSHIRE,ENGLAND
关键词
D O I
10.1016/0006-2952(92)90118-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The fluorescent probes warfarin and dansylsarcosine are known to selectively interact with binding sites I and II, respectively, on human albumin. This paper investigates whether similar binding sites exist on bovine, dog, horse, sheep and rat albumins. Binding sites on albumins were studied by: (1) displacement of warfarin and dansylsarcosine by site I (phenylbutazone) and site II (diazepam) selective ligands; (2) the effects of non-esterified fatty acids (carbon chain lengths: C5-C20) and changes in pH (6-9) on the fluorescence of warfarin and dansylsarcosine; and (3) the ability of site selective ligands to inhibit hydrolysis of 4-nitrophenyl acetate. For bovine, dog. horse, human and sheep albumins the fluorescence of bound warfarin and dansylsarcosine was selectively decreased by phenylbutazone and diazepam, respectively. For these albumins medium chain fatty acids (C-7-C-12) reduced the fluorescence of dansylsarcosine (maximum inhibition with C-9) whereas long chain acids (C-12-C20) enhanced the fluorescence of warfarin (maximum increases with C-12). In addition, changes in pH from 6 to 9 increased the fluorescence of warfarin and although site I ligands (warfarin/phenylbutazone) had no pronounced effects on 4-nitrophenyl acetate hydrolysis, site II ligands (dansylsarcosine/diazepam) significantly inhibited this reaction. Rat albumin behaved differently from the other albumins studied in that the C-12-C20 fatty acids and changes in pH did not enhance the fluorescence of warfarin. Moreover, the differential effects of site I and site II ligands on the fluorescence of warfarin/dansylsarcosine and hydrolysis of 4-nitrophenyl acetate were less apparent with rat albumin. The results suggest bovine, dog, horse and sheep albumins have binding sites for warfarin and dansylsarcosine with similar properties to sites I and II on human albumin. By contrast, the warfarin binding site and to a lesser degree the dansylsarcosine site, of rat albumin have different characteristics from these sites on the other albumins studied.
引用
收藏
页码:873 / 879
页数:7
相关论文
共 50 条
  • [1] A COMPARISON OF DRUG-BINDING SITES ON HUMAN AND CHICKEN ALBUMINS
    RAJAIAN, H
    SYMONDS, HW
    BOWMER, CJ
    BRITISH JOURNAL OF PHARMACOLOGY, 1995, 116 : P347 - P347
  • [2] OBJECTIVE MODELS OF DRUG-BINDING SITES
    CRIPPEN, GM
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1994, 208 : 137 - COMP
  • [3] DIFFERENTIATION OF THE DRUG-BINDING SITES OF CALMODULIN
    ZIMMER, M
    HOFMANN, F
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 1987, 164 (02): : 411 - 420
  • [4] Drug-binding albumins forming stabilized nanoparticles for efficient anticancer therapy
    Huang, Jianxiang
    Wu, Bihan
    Zhou, Zhuxian
    Hu, Shiqi
    Xu, Hongxia
    Piao, Ying
    Zheng, Hao
    Tang, Jianbin
    Liu, Xiangrui
    Shen, Youqing
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2019, 21
  • [5] COOPERATIVITY AMONG CALMODULINS DRUG-BINDING SITES
    MILLS, JS
    BAILEY, BL
    JOHNSON, DJ
    BIOCHEMISTRY, 1985, 24 (18) : 4897 - 4902
  • [6] COOPERATIVITY AMONG DRUG-BINDING SITES ON CALMODULIN
    MILLS, JS
    JOHNSON, JD
    BIOPHYSICAL JOURNAL, 1985, 47 (02) : A511 - A511
  • [7] HIGH-RESOLUTION LOCALIZATION OF DRUG-BINDING SITES
    HOFF, SF
    MACINNIS, AJ
    JOURNAL OF ULTRASTRUCTURE RESEARCH, 1981, 74 (02): : 205 - 216
  • [9] NEW DRUG-BINDING SITES IN CA2+ CHANNELS
    SPEDDING, M
    KENNY, B
    CHATELAIN, P
    TRENDS IN PHARMACOLOGICAL SCIENCES, 1995, 16 (04) : 139 - 142
  • [10] DEVELOPMENT OF DRUG-BINDING SITES IN HUMAN-FETAL BRAIN
    SCHLUMPF, M
    LICHTENSTEIGER, W
    TERATOLOGY, 1987, 36 (01) : A16 - A17